基于支架的核因子-kappaB诱的局部输送减轻了高胆固醇贫血子的支架内静止症
Kisho Ohtani1, Kensuke Egashira, Kaku Nakano
1Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Circulation
|November 30, 2006
概括
用诱支架阻断核因子-kappaB (NF-kappaB) 降低了支架内静止和新极端形成. 这种新的方法没有对愈合产生不良影响,这表明它是一种有前途的策略来预防复原.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物医学工程 生物医学工程
背景情况:
- 核因子-kappaB (NF-kappaB) 在血管损伤反应中至关重要.
- 它在静脉静脉复缩中的特定作用尚未完全理解.
- 这项研究探讨了NF-kappaB在缩机制中的作用.
研究的目的:
- 为了测试通过以支架为基础的诱输送来阻止NF-kappaB是否会减少支架内新极端的形成.
- 评估NF-kappaB诱排泄支架的安全性和有效性.
主要方法:
- NF-kappaB诱或控制聚合物涂层支架植入高胆固醇贫血的子 iliac 动脉.
- 评估NF-kappaB活动,单细胞透,MCP-1表达和CD14激活.
- 评估了28天后的新极端形成和血管愈合.
- 在体外评估光滑肌肉细胞增殖.
主要成果:
- 凝固后NF-kappaB活性增加,但被诱凝固抑制.
- 诱支架减少了单细胞透,MCP-1表达和CD14激活.
- 显著减弱了neointimal形成,而不会影响血管愈合.
- 在体外,NF-kappaB诱抑制了光滑肌肉细胞的增殖.
结论:
- 基于支架的NF-kappaB诱惑剂的输送有效地减少了支架内缩.
- 该策略表明没有证据表明不完全愈合.
- 这种方法在临床环境中有望预防静脉静脉复缩.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


